Literature DB >> 28577831

Stereotactic Body Radiotherapy for Liver Metastases.

Karyn A Goodman1, Brian D Kavanagh2.   

Abstract

Many cancers can spread to the liver, often as the sole site of metastatic disease. For properly selected patients with limited hepatic disease and good performance status, an aggressive strategy involving radical local therapy to the site(s) of metastasis offers a chance for extended disease-free survivorship. The development of stereotactic body radiotherapy has inserted radiation therapy into the arsenal of valuable treatment options in this clinical setting. This article summarizes the latest advancements in the use of stereotactic body radiotherapy to treat liver metastases.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28577831     DOI: 10.1016/j.semradonc.2017.02.004

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  8 in total

1.  Endovascular implantation of iodine-125 seed strand combined and stent placement for locally advanced pancreatic ductal adenocarcinoma with vascular invasion: a prospective single-arm pilot study.

Authors:  Linlin Wu; Yanbo Zhang; Zihan Zhang; Fengfeng Li; Jianjun Luo
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

2.  Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.

Authors:  Sabine Gerum; Christian Heinz; Claus Belka; Franziska Walter; Philipp Paprottka; Enrico N De Toni; Falk Roeder
Journal:  Radiat Oncol       Date:  2018-05-29       Impact factor: 3.481

3.  Evaluation of the intra- and interfractional tumor motion and variability by fiducial-based real-time tracking in liver stereotactic body radiation therapy.

Authors:  Zhiwen Liang; Hongyuan Liu; Jun Xue; Bin Hu; Bin Zhu; Qin Li; Sheng Zhang; Gang Wu
Journal:  J Appl Clin Med Phys       Date:  2018-02-28       Impact factor: 2.102

4.  Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.

Authors:  Cihan Gani; S Boeke; H McNair; J Ehlers; M Nachbar; D Mönnich; A Stolte; J Boldt; C Marks; J Winter; Luise A Künzel; S Gatidis; M Bitzer; D Thorwarth; D Zips
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-30

Review 5.  Magnetic Resonance Imaging-Guided Adaptive Radiotherapy for Colorectal Liver Metastases.

Authors:  Paul B Romesser; Neelam Tyagi; Christopher H Crane
Journal:  Cancers (Basel)       Date:  2021-04-01       Impact factor: 6.639

6.  Using the Diaphragm as a Tracking Surrogate in CyberKnife Synchrony Treatment.

Authors:  Guo-Quan Li; Jing Yang; Yan Wang; Mengjun Qiu; Zeyu Ding; Sheng Zhang; Sheng-Li Yang; Zhenjun Peng
Journal:  Med Sci Monit       Date:  2021-08-11

7.  Scores of Child-Pugh Classification Impact Overall Survival After Stereotactic Body Radiation Therapy for Primary and Metastatic Liver Tumors.

Authors:  Osamu Tanaka; Takao Kojima; Akihiro Ohbora; Chiyoko Makita; Takuya Taniguchi; Kousei Ono; Masayuki Matsuo; Yasushi Nagata
Journal:  J Clin Exp Hepatol       Date:  2019-05-21

Review 8.  Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?

Authors:  Sylvia S W Ng; Matthew S Ning; Percy Lee; Ryan A McMahon; Shankar Siva; Michael D Chuong
Journal:  Adv Radiat Oncol       Date:  2020-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.